Summit Financial Group’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$1.39M Buy
10,149
+870
+9% +$119K 0.5% 59
2023
Q4
$1.26M Hold
9,279
0.48% 60
2023
Q3
$1.13M Hold
9,279
0.48% 61
2023
Q2
$1.18M Hold
9,279
0.46% 63
2023
Q1
$1.2M Hold
9,279
0.45% 65
2022
Q4
$1.22M Buy
9,279
+700
+8% +$91.9K 0.48% 57
2022
Q3
$1M Hold
8,579
0.42% 71
2022
Q2
$1.01M Hold
8,579
0.39% 78
2022
Q1
$1.12M Buy
8,579
+100
+1% +$13K 0.38% 76
2021
Q4
$1.29M Sell
8,479
-6
-0.1% -$916 0.42% 68
2021
Q3
$1.37M Hold
8,485
0.5% 59
2021
Q2
$1.39M Sell
8,485
-315
-4% -$51.6K 0.52% 56
2021
Q1
$1.33M Buy
8,800
+55
+0.6% +$8.28K 0.55% 51
2020
Q4
$1.33M Buy
8,745
+140
+2% +$21.2K 0.58% 50
2020
Q3
$1.17M Buy
8,605
+35
+0.4% +$4.74K 0.58% 49
2020
Q2
$1.17M Buy
8,570
+145
+2% +$19.8K 0.61% 44
2020
Q1
$908K Hold
8,425
0.54% 51
2019
Q4
$1.02M Sell
8,425
-345
-4% -$41.6K 0.49% 52
2019
Q3
$873K Sell
8,770
-1,875
-18% -$187K 0.44% 57
2019
Q2
$1.16M Sell
10,645
-150
-1% -$16.4K 0.52% 52
2019
Q1
$1.21M Hold
10,795
0.94% 34
2018
Q4
$1.04M Hold
10,795
0.88% 37
2018
Q3
$1.32M Hold
10,795
0.98% 32
2018
Q2
$1.19M Hold
10,795
0.92% 34
2018
Q1
$1.15M Sell
10,795
-50
-0.5% -$5.34K 0.9% 37
2017
Q4
$1.16M Sell
10,845
-1,605
-13% -$171K 0.95% 36
2017
Q3
$1.38M Sell
12,450
-30
-0.2% -$3.34K 1.15% 28
2017
Q2
$1.29M Buy
+12,480
New +$1.29M 1.12% 27